pharmaphorum

SEPTEMBER 22, 2021

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. In the life sciences sector, the overall goal is to develop and commercialise innovative pharmaceutical solutions to improve health.

Pharma Companies 101

Pharma Companies Life Science Development Production 101

XTalks

MAY 29, 2024

The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccination 52

Drug Discovery World

DECEMBER 7, 2022

The programme is aimed at organisations seeking to develop leadership and mentoring skills and promote diversity in the life sciences work environment. The programme is aimed at organisations seeking to develop leadership and mentoring skills and promote diversity in the life sciences work environment.

Pharma Companies 52

Pharma Companies Life Science Regulation Scientist 52

XTalks

FEBRUARY 16, 2022

The drug was developed by Orchard Therapeutics and the NHS was able to negotiate a greater discount on it with the company so that it can offer it to patients in England. The team also talked about a digital risk report that revealed the existence of significant cybersecurity vulnerabilities among the world’s top pharma companies.

Life Science 52

Life Science Gene Therapy Drugs Pharma Companies 52

pharmaphorum

APRIL 19, 2022

The first focuses on the patient journey through patient partnerships – spotting areas of challenge for specific patients and developing partnerships with different stakeholders outside Roche to improve upon the patient journey. The post The largest pharma company in Europe calls for interoperability appeared first on.

Pharma Companies 99

Pharma Companies Life Science Clinical Research Research 99

The Pharma Data

DECEMBER 9, 2020

This partnership provides SOLABS’ Life Sciences clients with exciting capabilities in the areas of reporting and analytics. MONTREAL, QC, December 09, 2020 /24-7PressRelease/ — SOLABS enters into a partnership with NexGen Analytics. NexGen has primarily focused on the Life Sciences industry.

Life Science 52

Life Science Packaging Packaging Pharma Companies 52

Drug Discovery World

OCTOBER 12, 2023

BioMap has entered a strategic collaboration with Sanofi to co-develop AI modules for biotherapeutic drug discovery, leveraging BioMap’s AI platform. However, in life science, labeled data are often in short supply. Traditional AI methods require vast amounts of labeled data to make accurate predictions.

Development 52

Development Protein Life Science Pharma Companies 52

STAT News

FEBRUARY 13, 2023

Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma company Roche. and a leading researcher in cell biology.

Life Science 98

Life Science Pharma Companies Medicine Research 98

Drug Discovery World

JULY 2, 2024

DDW’s Diana Spencer takes a closer look into why Switzerland is such a life sciences powerhouse and how Swiss researchers are advancing new technology and tackling modern health challenges. Switzerland, however, boasts three (or arguably, four) separate yet complimentary centres of life science innovation.

Life Science 59

Life Science Drugs Development Research 59

XTalks

MAY 20, 2021

In this episode, Ayesha discusses the latest trends in pharma tv ad spending, including the top spenders last week. The pandemic has led to a rise in both TV watching and health awareness, which pharma companies took advantage of by increasing spending on TV commercials by about 17 percent overall.

Life Science 52

Life Science Pharma Companies Development Drugs 52

VirTrial

SEPTEMBER 21, 2020

The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharma companies.?. 2020 Accolades. About Fierce Innovation Awards.

Life Science 52

Life Science Clinical Research Coordinator Pharma Companies Clinical Research 52

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

XTalks

FEBRUARY 17, 2021

While an internal candidate search may seem easier at first glance, there are some inherent challenges associated with identifying and scoping out the relevant skills and expertise even within a company. This can be a particular problem in larger companies. The Importance of Both Expertise and Company Culture.

Life Science 97

Life Science HR Clinical Research Clinical Trials 97

XTalks

MARCH 30, 2022

Whether you are building a workable plan from scratch or simply improving it, the following methods can help develop your diversity and inclusion framework. Pharma companies must ensure that diversity and inclusion programs are taken seriously and turn them into long term components of their diversity and inclusion framework plan.

Pharma Companies 59

Pharma Companies Life Science Engineer Development 59

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. This included more than £6bn ($7.3bn) being made available by the UK Government in November 2020 for the development and procurement of successful vaccines.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Genetic Disease Development 225

Drug Discovery World

OCTOBER 6, 2022

With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. According to McKinsey & Company: “Europe’s complex biotech landscape comprises hundreds of companies, dozens of countries, and multiple paths to innovation and financing… .

Development 52

Development Drugs Life Science Marketing 52

XTalks

OCTOBER 4, 2023

How do you make strategic decisions around products that are in the early stage of development and are still years from regulatory approval and launch? In the specialized, personalized and advanced medicines spaces, this work should start very early — as early as Phase I or Phase II of clinical development.

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

DECEMBER 14, 2022

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. November saw the launch of a new private equity team in life sciences at J.P. Morgan Asset Management, dubbed Life Sciences Private Capital. New CEO joins UBC.

Life Science 96

Life Science Gene Therapy Gene Editing Gene 96

pharmaphorum

JUNE 6, 2022

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. pic.twitter.com/MUKcXaganu. — Limitless Minds (@Thinkbig_gofar) July 25, 2019.

Sales 97

Sales Life Science Pharma Companies Marketing 97

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

Drug Discovery World

FEBRUARY 10, 2023

Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS.

Vaccination 141

Vaccination Vaccine Manufacturing Clinical Development 141

Pharmaceutical Technology

JULY 26, 2022

Following the merger, NewAmsterdam Pharma CEO Dr Michael Davidson will lead the newly formed holding company, which is expected to be named NewAmsterdam Pharma Company. In January last year, NewAmsterdam Pharma raised $196m in a Series A funding round to support the full Phase III development of obicetrapib.

Life Science 147

Life Science Trials Pharma Companies Production 147

pharmaphorum

NOVEMBER 8, 2022

Ask nearly any pharma company these days if they’re patient-centric, and you’ll probably get an answer in the affirmative. Suchotliff sat down with Deep Dive to discuss the current state of patient centricity in pharma, some of the common foibles and misconceptions, and how pharma companies can get themselves on the right track. “I

Life Science 52

Life Science Pharma Companies Branding Development 52

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. This article takes a closer look at several key clusters in the region.

Drugs 59

Drugs Life Science Gene Editing Gene 59

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

Drug Discovery World

OCTOBER 18, 2022

The second phase will see it develop a methodology for calculating the carbon footprint of both trial models. The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. Growing pressure on life sciences.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

SEPTEMBER 3, 2020

The area is being reimagined as a life sciences and technology hub and is already home to the Francis Crick Institute biomedical research organisation. With AI the pharma industry hopes to reduce the number of drugs that fail during the clinical development process, a huge financial drain on the industry.

Life Science 96

Life Science Engineer Scientist Pharma Companies 96

Drug Discovery World

OCTOBER 16, 2023

Cambridge boasts the world-renowned university alongside a biotech and pharma cluster situated throughout the city and its surrounding science parks, all of which helps attract top scientific talent.” The university aims to identify treatments for life-threatening anti-microbial diseases and metabolic disorders.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . BioNTech seeks “new kind of pharma company”.

Development 81

Development Drugs Vaccination Vaccine 81

Drug Discovery World

DECEMBER 14, 2023

With leading academic institutions and significant recent investment, Glasgow is shaping up to be an important centre for drug discovery and development in the UK. A centre of excellence for cancer research The announcement of the new Health Innovation Hub follows other examples of significant investment in Glasgow life sciences.

Drugs 75

Drugs Life Science Research Scientist 75

pharmaphorum

DECEMBER 7, 2021

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them.

Life Science 94

Life Science Pharma Companies Branding Marketing 94

pharmaphorum

MAY 12, 2022

German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor drug safety data to ArisGlobal, which provides cloud software to life sciences companies. ” The post Boehringer sells drug safety software to ArisGlobal appeared first on.

Drugs 52

Drugs Life Science Pharma Companies Development 52

pharmaphorum

JANUARY 10, 2023

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. The combination of health and data, he passionately believes, will transform life sciences. And he has a unique view of how data and health combine.

Marketing 98

Marketing Life Science Sales Branding 98

pharmaphorum

MAY 13, 2021

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Rather than simply surviving, the life sciences industry needs to respond proactively. About Veeva Systems.

Life Science 79

Life Science Sales Pharma Companies Production 79

pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. “There isn’t a one-size-fits-all for how the life sciences industry creates content.

Life Science 78

Life Science Compliance Production Pharma Companies 78